PRACTICE NOTE 17 / GUIDANCE NOTE 3 : REGULARISATION PLAN
| PHARMANIAGA BERHAD |
| Type | Announcement |
| Subject | PRACTICE NOTE 17 / GUIDANCE NOTE 3 REGULARISATION PLAN |
| Description | PHARMANIAGA BERHAD ("PHARMANIAGA" OR THE "COMPANY")
PROPOSED REGULARISATION PLAN |
|
(The abbreviations used throughout this announcement shall have the same meaning as those defined in the announcements dated 29 November 2023 and 19 February 2024 in relation to the Initial Proposed Regularisation Plan and the Proposed Regularisation Plan respectively, unless stated otherwise or defined herein). On behalf of the Board, MIDF Investment wishes to announce that the application in relation to the Proposed Regularisation Plan has been submitted to Bursa Securities on 23 February 2024. This announcement is dated 23 February 2024. |
|
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 23 Feb 2024 |
| Category | General Announcement for PLC |
| Reference Number | GA1-23022024-00053 |